Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTR1A pseudogene 1 (ACTR1AP1), also known as ARP1 actin related protein 1 homolog A pseudogene, is a pseudogene related to the ACTR1A gene rather than a functional protein-coding gene[3]. It is a pseudogene associated with the protein-coding gene ACTR1A, which encodes actin-related protein 1 homolog A[3]. Pseudogenes are typically non-functional genomic DNA sequences similar to normal genes but do not encode functional proteins or have direct roles in cellular pathways. There is no evidence that ACTR1AP1 is a therapeutic target, biomarker, or drug-interaction receptor. It may appear in some genomic databases, but it is not used as a protein or drug target in biomedical research. Therefore, ACTR1AP1 refers to a pseudogene, not the functional protein ACTR1A, and should not be considered a molecular/receptor target for therapeutic development or pathology[3]. If information on the protein, rather than the pseudogene, is required, refer to ACTR1A and its role in the dynactin complex[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTR1A pseudogene 1 (ACTR1AP1).